These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 6479679

  • 21. [Antithrombin III and alpha-2-antiplasmin activities compared with other hemostasis parameters in uncomplicated diabetes mellitus, type 2].
    Kotschy M, Drewniak W, Graczykowska-Koczorowska A, Listopadzki D.
    Pol Tyg Lek; ; 47(1-2):17-8. PubMed ID: 1409034
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effects of exploratory laparotomy on plasma and peritoneal coagulation/fibrinolysis in horses.
    Baxter GM, Parks AH, Prasse KW.
    Am J Vet Res; 1991 Jul; 52(7):1121-7. PubMed ID: 1892267
    [Abstract] [Full Text] [Related]

  • 24. Influence of anaesthesia on coagulation and fibrinolytic proteins.
    Richard LC, Büller HR, Bovilland J, ten Cate JW.
    Br J Anaesth; 1983 Sep; 55(9):869-72. PubMed ID: 6615674
    [Abstract] [Full Text] [Related]

  • 25. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F, Watanabe M, Nishikawa M, Shiku H, Nobori T.
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Low-dose danazol in the treatment of livedoid vasculitis.
    Hsiao GH, Chiu HC.
    Dermatology; 1997 Jan; 194(3):251-5. PubMed ID: 9187843
    [Abstract] [Full Text] [Related]

  • 28. Changes in the coagulation and fibrinolytic systems during and after cardiopulmonary bypass surgery.
    Kongsgaard UE, Smith-Erichsen N, Geiran O, Bjørnskau L.
    Thorac Cardiovasc Surg; 1989 Jun; 37(3):158-62. PubMed ID: 2527423
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Synthetic peptide substrate assays in coagulation and fibrinolysis and their application on automates.
    Friberger P.
    Semin Thromb Hemost; 1983 Oct; 9(4):281-300. PubMed ID: 6362011
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Time course and prognostic significance of hemostatic changes in sepsis: relation to tumor necrosis factor-alpha.
    Martínez MA, Peña JM, Fernández A, Jiménez M, Juárez S, Madero R, Vázquez JJ.
    Crit Care Med; 1999 Jul; 27(7):1303-8. PubMed ID: 10446824
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Clinical significance of antithrombin III, plasminogen and alpha 2-plasmin inhibitor in perinatal period.
    Fuse Y, Fuse K.
    Asia Oceania J Obstet Gynaecol; 1985 Mar; 11(1):121-5. PubMed ID: 3160323
    [No Abstract] [Full Text] [Related]

  • 35. The extent of diffuse intravascular coagulation and fibrinolysis in patients with liver cirrhosis.
    van Wersch JW, Russel MG, Lustermans FA.
    Eur J Clin Chem Clin Biochem; 1992 May; 30(5):275-9. PubMed ID: 1627724
    [Abstract] [Full Text] [Related]

  • 36. Adaptation of synthetic peptide substrate-based assays on a discrete analyzer.
    Aiach M, Léon M, Michaud A, Capron L.
    Semin Thromb Hemost; 1983 Jul; 9(3):206-16. PubMed ID: 6351255
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Automated instrumentation and the laboratory diagnosis of bleeding and thrombotic disorders.
    Walenga J, Fareed J, Bermes EW.
    Semin Thromb Hemost; 1983 Jul; 9(3):172-93. PubMed ID: 6351253
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.